Avigen News
Most Popular Avigen Story
BVF urges stakeholders to dump Avigen board
Biotechnology Value Fund, which holds a 30 percent stake in Avigen, will finally get that special shareholders meeting it's been pushing for later this month. The firm is urging fellow stockholders... Read more...
Latest Headlines
- August 21, 2009
- June 26, 2009
- March 26, 2009
- March 13, 2009
- February 6, 2009
- January 26, 2009
- December 23, 2008
- December 22, 2008
- November 4, 2008
- October 21, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
